ArticleJournal of controlled release : official journal of the Controlled Release Society2022

CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice.

Vipul K Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.